pancreatic cancer Clinical Trials and Research
Also known as: pancreatic ductal adenocarcinoma, cancer of the pancreas, pancreas cancer, exocrine pancreatic cancer, pda · ICD-10: C25
Pancreatic cancer is a serious disease where abnormal cells grow in the pancreas. Current clinical trial research focuses on developing new therapies, improving early detection methods, and understanding disease progression to enhance patient outcomes. Find a Trial helps patients and caregivers search for active studies.
Search pancreatic cancer trials →
Common questions about pancreatic cancer clinical trials
What types of pancreatic cancer are studied in clinical trials?
Most trials focus on adenocarcinoma, the most common type. Other studies investigate rarer forms like neuroendocrine tumors. Research aims to find effective treatments for all types, as reported on ClinicalTrials.gov.
What are common eligibility criteria for pancreatic cancer trials?
Criteria often include the specific cancer stage, previous treatments, and overall health status. Patients usually need to meet certain lab test results and performance scores to ensure safety and study relevance, as detailed on ClinicalTrials.gov.
What phases of clinical trials are relevant for pancreatic cancer?
All phases are relevant. Phase 1 trials test new treatments for safety, Phase 2 assess effectiveness, and Phase 3 compare new treatments to standard care. Phase 4 studies monitor approved treatments, as seen on ClinicalTrials.gov.
What new treatment approaches are being investigated for pancreatic cancer?
Researchers are exploring immunotherapies, targeted therapies that block specific cancer growth pathways, and novel chemotherapy combinations. Studies also investigate advanced surgical techniques and radiation therapies, according to data from NIH RePORTER.
Are there clinical trials for early-stage pancreatic cancer?
Yes, trials for early-stage pancreatic cancer often focus on improving surgical outcomes, testing adjuvant therapies after surgery, or developing better screening methods for high-risk individuals. These studies aim to prevent recurrence, as noted on ClinicalTrials.gov.
What biomarkers are important in pancreatic cancer research?
Biomarkers like CA 19-9 are commonly used, but researchers are investigating new genetic and molecular markers. These help predict treatment response, monitor disease progression, and identify patients for targeted therapies, according to NIH RePORTER.
Do clinical trials for pancreatic cancer cover treatment costs?
Generally, the study sponsor covers the costs of the experimental treatment and study-related tests. Routine medical care costs, however, are typically billed to the patient's insurance, as outlined in trial protocols on ClinicalTrials.gov.
What are common reasons a patient might be excluded from a pancreatic cancer trial?
Exclusion criteria often include uncontrolled co-existing medical conditions, prior treatments that might interfere with the study drug, or specific lab abnormalities. These ensure patient safety and the integrity of the research, as specified on ClinicalTrials.gov.
How to find a pancreatic cancer trial that fits you
- Describe your pancreatic cancer situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all pancreatic cancer trials →